Crohn's disease — the surgical perspective

Published by the practice of Charalambos Charalambous, MD, ChM, General Surgeon, German Medical Institute, Limassol, Cyprus. Last updated: 19 September 2026.

Crohn's disease is a chronic inflammatory condition that can affect any part of the digestive tract. It is a medical disease treated primarily by gastroenterologists, and surgery does not cure it. Nevertheless a majority of patients require an operation at some point, and the way that surgery is planned and performed has a substantial bearing on how much bowel they still have twenty years later. This page is written from the surgical perspective — when an operation helps, what it can and cannot achieve, and the principles that protect the bowel over a lifetime.

How it develops

Crohn's disease arises from a disordered immune response to the gut's own bacterial population, in a genetically susceptible person, triggered or modified by environmental factors.

• Genetic susceptibility — over two hundred susceptibility loci are known. The best characterised is NOD2, which encodes a sensor recognising bacterial cell wall fragments. Variants impair the initial handling of bacteria by the innate immune system. Genes governing autophagy (ATG16L1, IRGM) are also implicated: impaired autophagy means intracellular bacteria are cleared less effectively.
• Barrier failure — the intestinal epithelium and its mucus layer normally separate bacteria from the immune system. Increased permeability allows bacterial products through.
• Immune dysregulation — the response, once triggered, fails to resolve. T-cell-driven inflammation is sustained by TNF-α, interleukin-12 and interleukin-23 and the Th17 pathway. These are precisely the targets of modern biological therapy, which is why those drugs work.
• Environment — smoking is the single most important modifiable factor and notably worsens Crohn's disease while appearing protective in ulcerative colitis. Diet, antibiotics in early life and the microbiome all contribute.

Why the pattern of damage matters surgically

The inflammation in Crohn's is transmural — through the full thickness of the bowel wall — and discontinuous, with skip lesions separating affected from normal segments. Granulomas may be present. Two consequences follow directly and account for nearly all the surgery performed:

• Transmural inflammation heals by fibrosis, producing strictures and obstruction.
• Transmural inflammation can penetrate the wall entirely, producing fistulas — to other bowel loops, to the bladder, to the vagina, to the skin — and abscesses.

Disease is classified by the Montreal classification according to age at onset, location (ileal, colonic, ileocolonic, upper gastrointestinal) and behaviour (inflammatory, stricturing, penetrating), with perianal disease noted separately. Behaviour tends to progress from inflammatory to stricturing or penetrating over years, which is the rationale for treating effectively early.

Symptoms

• abdominal pain, classically in the right lower abdomen with terminal ileal disease
• diarrhoea, sometimes with blood, particularly in colonic disease
• weight loss and fatigue
• fever
• obstructive symptoms — colicky pain after eating, distension, vomiting — indicating stricture
• a right iliac fossa mass
• perianal disease — fistulas, abscesses, fissures and skin tags, which may precede intestinal symptoms by years and are a common route to diagnosis
• growth failure and delayed puberty in children
• extraintestinal features — joint pain and arthritis, erythema nodosum, pyoderma gangrenosum, eye inflammation, and primary sclerosing cholangitis
• anaemia, and deficiency of iron, B12 (with terminal ileal disease or resection) and vitamin D

How the diagnosis is made

No single test establishes it; the diagnosis rests on a combination.

• Blood tests — inflammatory markers, anaemia, nutritional indices.
• Faecal calprotectin — a sensitive marker of intestinal inflammation, useful for distinguishing inflammatory from functional symptoms and for monitoring.
• Ileocolonoscopy with biopsies — the cornerstone, demonstrating patchy inflammation, aphthous and deep linear ulcers, cobblestoning, and histological features including granulomas.
• MR enterography — the key imaging investigation, defining the extent and length of small bowel disease, distinguishing active inflammation from fibrotic stricture, and identifying fistulas and abscesses, without radiation.
• CT in the acute setting.
• Pelvic MRI for perianal disease — essential before any perianal surgery, to map fistula tracks and identify abscesses.
• Capsule endoscopy for small bowel disease not otherwise demonstrated, with a patency capsule first where stricture is possible.

Distinguishing Crohn's colitis from ulcerative colitis matters, since it determines whether restorative surgery with a pouch is an option.

Medical treatment

Managed by gastroenterologists, and summarised here because surgical decisions cannot be made in isolation from it. Corticosteroids induce remission but are not maintenance treatment. Immunomodulators (azathioprine, methotrexate) and biological agents — anti-TNF drugs, anti-integrin and anti-interleukin-12/23 agents, and newer small molecules — maintain remission and heal the mucosa. Early effective treatment in patients with poor prognostic features reduces later complications. Nutritional therapy, particularly exclusive enteral nutrition, is highly effective in children and useful before surgery in adults.

Surgery

When it is needed

Surgery does not cure Crohn's disease, and this must be understood from the outset. It treats the complications, and a well-timed operation can restore quality of life dramatically after years of symptoms. Indications:

• Obstruction from a fibrotic stricture — the commonest. A fibrotic stricture will not respond to any drug, and continuing medical treatment in that situation simply delays the inevitable while the patient remains unwell.
• Abscess — usually drained percutaneously first.
• Fistula causing symptoms — enterocutaneous, enterovesical, enterovaginal.
• Perforation or significant bleeding.
• Failure of medical treatment, or intolerable side effects — and this deserves emphasis: for limited terminal ileal disease, early resection compares favourably with escalating to biological therapy, both in quality of life and cost. It should be offered as a genuine alternative, not held back as a last resort.
• Dysplasia or cancer, which carries increased risk in long-standing colonic disease.
• Growth failure in children.

The governing principle: preserve bowel

Because the disease recurs and the patient may need further operations over decades, every operation must conserve intestinal length. Short bowel syndrome in Crohn's is nearly always the cumulative result of repeated generous resections rather than of the disease itself.

• Resect only what is diseased. Wide margins confer no benefit — recurrence rates are the same with a 2cm margin as with 12cm. Macroscopically normal bowel is left alone, and microscopic involvement at the margin does not require further resection.
• Strictureplasty — widening a stricture without removing bowel, by opening it longitudinally and closing it transversely (Heineke-Mikulicz) or, for longer segments, by side-to-side techniques (Finney, Michelassi). Invaluable in multiple strictures and in patients who have already lost bowel.
• Endoscopic balloon dilatation for short, accessible strictures, particularly at a previous anastomosis.
• Laparoscopic surgery is standard for primary ileocolic resection, with less adhesion formation — which matters when further surgery is likely.
• Kono-S anastomosis, an antimesenteric functional end-to-end technique, appears to reduce recurrence at the join and is increasingly used.
• A temporary stoma is used where the patient is malnourished, septic, or on high-dose steroids, as an anastomosis in those conditions is at high risk of leaking.

Perianal disease

Treated jointly, and with restraint. Abscesses are drained. Fistulas are managed with draining setons — soft threads keeping the track open and preventing recurrent abscess — combined with medical therapy, usually anti-TNF treatment. Definitive fistula surgery is attempted only once inflammation is controlled, because aggressive division of sphincter muscle in Crohn's disease risks incontinence in a patient who may have years of diarrhoea ahead. Proctectomy with permanent stoma is a last resort for severe destructive disease, and for some patients an enormous improvement.

Preparing for surgery

Optimisation before an elective operation materially reduces complications: nutritional support, correction of anaemia, drainage of any abscess, weaning of corticosteroids, and stopping smoking. Rushing a malnourished patient on steroids into a resection is how leaks happen.

Recovery and recurrence

After laparoscopic ileocolic resection, hospital stay is typically three to five days and return to normal activity four to six weeks. Many patients feel better than they have for years.

Recurrence is expected and should be planned for rather than feared. It typically begins at the anastomosis. Endoscopic recurrence is common within a year, though clinical recurrence is slower. Postoperative prophylactic medical treatment, guided by risk factors — smoking, penetrating disease, previous resection, young age at onset — substantially reduces it. A colonoscopy at six to twelve months after surgery to assess the anastomosis is standard practice and guides whether treatment is escalated.

Stopping smoking is the single most effective thing a patient with Crohn's disease can do, and it approximately halves the risk of recurrence after surgery. No drug offers a comparable benefit.

Follow-up

Shared with gastroenterology: monitoring of disease activity with calprotectin and endoscopy, nutritional surveillance including B12 after ileal resection, bone density, and colonoscopic surveillance for dysplasia in long-standing colonic disease.

When to seek an opinion

Persistent diarrhoea with weight loss, abdominal pain with vomiting or distension, perianal abscess or fistula, or a known diagnosis with recurrent obstructive symptoms. Severe abdominal pain, fever or an inability to keep fluids down requires urgent assessment.

Common questions

Will surgery cure my Crohn's?

No, and it is important to be clear about that. Surgery treats the complications — a blockage, an abscess, a fistula — and often produces a dramatic improvement in how you feel. But the disease can return, usually at the join, which is why medication after surgery and a check colonoscopy within the first year are both part of the plan.

If it comes back, is surgery worth having?

Frequently, yes. A narrowing made of scar tissue will not respond to any drug, no matter how strong, so continuing medication in that situation only delays relief. A well-timed operation for the right problem can give years of feeling well, and many people say afterwards they wish they had had it sooner.

Will I lose a lot of bowel?

Not if surgery is done on modern principles. Only the visibly diseased segment is removed, and wide margins have been shown to give no benefit. Where there are several narrowings, they can often be widened rather than removed, preserving length. This matters because you may need further surgery over a lifetime.

Will I need a bag?

Usually not. Most operations join the bowel back together. A temporary stoma is used where the circumstances make a join risky — significant malnutrition, infection, or high-dose steroids — and is reversed once you are better. A permanent stoma is reserved for severe disease of the rectum and anus, and for some people is a considerable relief.

Does smoking really matter that much?

Yes. It is the strongest thing within your control. Smokers have more severe disease, need more operations, and have roughly double the risk of recurrence after surgery. Stopping produces a bigger benefit than any single medication.

Why do I need a colonoscopy soon after my operation if I feel fine?

Because the disease returns at the join before it produces symptoms, and finding that early allows treatment to be adjusted before damage accumulates. Feeling well is reassuring but not the same as the bowel being well.

Is it inherited?

There is a genetic component, and risk is higher if a close relative is affected, but most children of people with Crohn's disease never develop it. It is not passed on in a simple predictable way, and no genetic test is used for screening relatives.

Should I follow a special diet?

There is no single Crohn's diet. During a flare, or with a narrowing, a low-fibre diet reduces symptoms. Liquid feed diets are genuinely effective at settling inflammation, particularly in children and before surgery. Otherwise, the aim is adequate nutrition, with correction of specific deficiencies such as iron, vitamin B12 and vitamin D, guided by testing rather than guesswork.

Related conditions

Other conditions of the colon & rectum covered on this site:

• Colon cancer
• Rectal cancer
• Bowel polyps (colorectal polyps)
• Diverticular disease and diverticulitis
• Ulcerative colitis — the surgical perspective
• Large bowel obstruction and volvulus
• Appendicitis
• Hereditary bowel cancer syndromes (Lynch syndrome and FAP)

This page provides general information and does not replace an individual medical consultation. Crohn's disease is managed jointly with a gastroenterologist, and treatment is decided for each patient individually.